IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.
Saved in:
| Title: | IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening. |
|---|---|
| Authors: | Pohly MF; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Putzker K; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany., Scheinost S; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Ben Taarit L; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Walther T; Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Kummer S; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Wertheimer T; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Lin M; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Do THL; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Handler K; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Michler J; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kivioja J; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Bach K; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kisele S; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Kim J; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Dietrich S; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, University Hospital of Düsseldorf, Düsseldorf, Germany., Bornhauser B; Department of Pediatric Oncology, University Children's Hospital, University of Zurich, Zurich, Switzerland., Wong WW; Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Becher B; Department of Inflammation Research, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland., Moor A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Lewis J; Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.; Anavo Therapeutics, Heidelberg, Germany., Ficht X; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Lu J; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Huber W; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Molecular Medicine Partnership Unit, Heidelberg, Germany., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. |
| Source: | Blood [Blood] 2025 May 15; Vol. 145 (20), pp. 2336-2352. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
